CAS 1303996-67-9

(R)-Valiolamine Voglibose Dihydrochloride

Kontrolliertes Produkt

CAS: 1303996-67-9

Stability Hygroscopic
Applications (R)-Valiolamine Voglibose is the main R-enantiomeric intermediate of Voglibose (V750000), an α-glucosidase inhibitor that works by delaying the digestion and absorption of carbohydrates, thereby inhibiting postprandial hyperglycemia and hyperinsulinemia.
References Chen, X.L., et al.: Curr. Med. Chem., 13, 109 (2006);

Formel: C₁₇H₃₆Cl₂N₂O₁₁

Farbe und Form: Off White Solid

Molekulargewicht: 515.38

Ref: TR-V094390

(R)-Valiolamine voglibose dihydrochloride

CAS: 1303996-67-9

(R)-Valiolamine voglibose dihydrochloride is an analog of voglibose that acts as a potent inhibitor of alpha-glucosidases. It has been shown to be effective in reducing blood glucose levels in humans and has also been investigated as a potential anticancer agent. (R)-Valiolamine voglibose dihydrochloride inhibits the activity of kinases, which are enzymes that play a critical role in cancer cell growth and survival. This inhibition leads to the induction of apoptosis and the suppression of tumor growth. Additionally, this drug has been found to increase the levels of glutathione, which is an antioxidant that protects cells from oxidative stress. (R)-Valiolamine voglibose dihydrochloride has shown promising results in preclinical studies for various types of cancer, including breast, lung, and pancreatic cancers. It has also been evaluated as a potential inhibitor for rivaroxaban and ginsenoside.

Formel: C₁₇H₃₄N₂O₁₁

Reinheit: Min. 95%

Molekulargewicht: 442.5 g/mol

Ref: 3D-DCC99667

Voglibose Impurity 3

CAS: 1303996-67-9

Formel: C₁₇H₃₄N₂O₁₁

Molekulargewicht: 442.46

Ref: ST-EA-CP-V19004

(R)-Valiolamine Voglibose

CAS: 1303996-67-9

Formel: C₁₇H₃₄N₂O₁₁

Farbe und Form: White To Off-White Solid

Molekulargewicht: 442.47

Ref: 4Z-V-034001